The Journal of Experimental Medicine
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published 1 November 2004. doi:10.1084/jem.20041129
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 200, Number 9, 1179-1187
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 548K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oliver, P. M.
Right arrow Articles by Marrack, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oliver, P. M.
Right arrow Articles by Marrack, P.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Loss of Bim Allows Precursor B Cell Survival But Not Precursor B Cell Differentiation in the Absence of Interleukin 7

Paula M. Oliver1, Michael Wang2, Yanan Zhu5, Janice White1, John Kappler1,3,4, and Philippa Marrack1,3,5

1 Howard Hughes Medical Institute and Integrated Department of Immunology, National Jewish Medical and Research Center
2 Department of Pediatrics, University of Colorado Health Sciences Center, Denver, CO 80206
3 Department of Medicine, University of Colorado Health Sciences Center, Denver, CO 80206
4 Department of Pharmacology, University of Colorado Health Sciences Center, Denver, CO 80206
5 Department of Biochemistry and Molecular Genetics, University of Colorado Health Sciences Center, Denver, CO 80206

Address correspondence to Philippa Marrack, Howard Hughes Medical Institute, Dept. of Immunology, 1400 Jackson St., Denver, CO 80206. Phone: (303) 398-1324; Fax: (303) 398-1396; email: marrackp{at}njc.org

Interleukin (IL)-7 is a stromal cell–derived cytokine required for the survival, proliferation, and differentiation of B cell precursors. Members of the Bcl-2 family of proteins are known to have profound effects on lymphocyte survival, but not lymphocyte differentiation. To distinguish the relative dependence on IL-7 of B cell precursor survival versus B cell differentiation, the combined effects of lack of IL-7 and lack of the proapoptotic Bcl-2 relative, Bim, were studied. Bim is expressed to varying degrees in all B cell precursors and B cells. Lack of Bim compensated for lack of IL-7 in the survival of pro–, pre–, and immature B cells; however, lack of Bim did not substitute for the requirement for IL-7 in B cell precursor differentiation or B cell precursor proliferation. Precursor B cell survival is more dependent on sufficient levels of IL-7 than precursor B cell differentiation because the number of B cells and their precursors were reduced by half in mice heterozygous for IL-7 expression, but were restored to normal numbers in mice also lacking Bim. Hence, Bim and IL-7 work together to control the survival of B cell precursors and the number of B cells that exist in animals.

Key Words: Bim • B cell development • IL-7 • B cell survival • Bcl-2 family

Abbreviations used in this paper: CFSE, carboxyfluorescein diacetate succinimidyl ester; CLP, common lymphoid precursor; TSLP, thymic stromal lymphopoetin.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS